<i>SLCO1B1</i> Variants and Statin-Induced Myopathy — A Genomewide Study

Abstract

We have identified common variants in SLCO1B1 that are strongly associated with an increased risk of statin-induced myopathy. Genotyping these variants may help to achieve the benefits of statin therapy more safely and effectively. (Current Controlled Trials number, ISRCTN74348595.)